-
Thematic Analysis
Batteries in Aerospace and Defense – Thematic Intelligence
Batteries in Aerospace and Defense Thematic Report Overview In the coming decades, advancements in energy storage and batteries will play a critical role in the future of aerospace, defense, and security. The development of electric military vehicles, electric aircraft, electric vertical take-off and landing (eVTOL) aircraft, and other electronics will have a sizable impact on warfare. Meanwhile, China’s control of the entire global supply chain, from mines and refiners to component markers and cell producers, is a mounting geopolitical issue....
-
Thematic Analysis
Quantum Computing – Thematic Intelligence
Quantum Computing Theme Analysis Report Overview Quantum computers use the properties of quantum physics to store data and perform computations. There are many technologies with the potential to build their foundational quantum bits (qubits). However, it may well be over a decade before companies can deliver the enmeshed systems of high-fidelity qubits needed to usher in the quantum era. The fiendishly difficult engineering problems, excess hype, and pre-revenue phase for many quantum companies mean a protracted quantum winter is in...
-
Track & Monitor
Batteries in automotive: Li-ion secondary battery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Li-ion secondary battery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Batteries in automotive: Mixed-metal oxide Li-ion battery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Mixed-metal oxide Li-ion battery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Product Insights
Ahlstrom Kiinteistot/ Aktia LI/ CPF – EriCa Green Chemistry Park – Uusimaa
The Ahlstrom Kiinteistot/ Aktia LI/ CPF – EriCa Green Chemistry Park – Uusimaa project includes the construction of the EriCa Green Chemistry Park in, Espoo, Uusimaa, Finland. Equip yourself with the essential tools needed to make informed and profitable decisions with our Ahlstrom Kiinteistot/ Aktia LI/ CPF – EriCa Green Chemistry Park – Uusimaa report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danburstotug in T-Cell Lymphomas
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Danburstotug in T-Cell Lymphomas Drug Details: STIA-1015 is under development for the treatment of solid...
-
Product Insights
NewCartilage Degeneration – Drugs In Development, 2024
Empower your strategies with our Cartilage Degeneration – Drugs In Development, 2024 report and make more profitable business decisions. Cartilage is a connective tissue of bone that protects bones and joints. Degeneration or destruction of cartilage results from both synovial-dependent and synovial-independent processes. Synovial fluid present in joints acts as a shock observer and a lubricant. Cartilage degeneration is commonly seen in osteoarthritis. OA is a degenerative inflammatory joint disease where the tissue in the joints breaks down overtime. Joint pain...
-
Product Insights
NewInfluenza A Virus, H3N2 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H3N2 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. H3N2 infections are caused by variant H3N2 virus, which is a strain of influenza. Symptoms include cough, sore throat, runny or stuffy nose, chills, nausea, vomiting, and/or diarrhea. Risk factors include age and chronic medical conditions like asthma, diabetes, heart disease, weakened immune systems, and neurological or neurodevelopment conditions. Treatment includes antiviral medications and antibiotics. The Influenza A...
-
Product Insights
NewRabies – Drugs In Development, 2024
Empower your strategies with our Rabies – Drugs In Development, 2024 report and make more profitable business decisions. Rabies is a deadly virus spread to people from the saliva of infected animals. The rabies virus is usually transmitted through a bite. Symptoms include loss of feeling in an area of the body, loss of muscle function, difficulty swallowing, excitability, fever, and convulsions. The predisposing factors include exposure to wildlife and exposure to pets that are not vaccinated. The Rabies drugs in...
-
Product Insights
NewInfluenzavirus B Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus B Infections – Drugs In Development, 2024 report and make more profitable business decisions. Type B influenza is a subtype of the influenza virus that tends to occur sporadically. Symptoms include runny nose, sore throat, aching muscles, malaise, watery eyes, aching body, loss of appetite, and weakness. Treatment includes antivirals, analgesics, and antipyretics medications. The Influenzavirus B Infections drugs in development market research report provide comprehensive information on the therapeutics under development for Influenzavirus B...